Pyridinone and pyridinethione derivatives having HIV...

Details Pyridinone and pyridinethione derivatives having HIV... Pyridinone and pyridinethione derivatives having HIV...

2006-10-03

2006-10-03

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S340000, C514S341000, C514S345000, C544S360000, C546S268100, C546S300000, C546S301000

Reexamination Certificate

active

07115608

ABSTRACT:
The present invention is concerned among others with compounds of formula (1), the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and stereochemically isomeric forms thereof, wherein Q is halo, C1-6alkyl or C2-6alkenyl; X is (a-2) with q and r being O and Z being O, S or SO; R1is aryl; R2is selected from formyl; C1-6alkyloxycarbonylalkyl; Het2; Het2C1-6alkyl, C1-6alkylthio; C1-6alkyl optionally substituted with one or two substituents each independently selected from hydroxy, and halo; R3is selected from formyl; C1-6alkyl optionally substituted with one or two C1-6alkyloxy; R4is hydrogen, with HTV inhibiting properties

REFERENCES:
patent: WO97/05113 (1997-02-01), None
patent: WO 97/19923 (1997-07-01), None
patent: WO97/37977 (1997-10-01), None
patent: WO99/55676 (1999-11-01), None
patent: WO00/00475 (2000-01-01), None
Dolle, V. et al, “A New Series of Pyridinone Derivatives as Potent Non-Nucleoside Human Immunodeficiency Virus Type 1 Specific Reverse Transcriptase Inhibitors”, J.Med.Chem, vol. 38, No. 23 , Oct. 15, 1995, pp. 4679-4686.
Kolder, C.R. et al, “Tautomerism of Hydroxypyridines—(II) Bromination of 2,4-Dihydroxypyridines and its Ethyl Derivatives”, Chemical Abstracts, No. CA55:1608f, XP-002190994.
Ran, C. et al, “Synthesis and bio-activity study of the 2(1H)-quinolone compounds”, Chemical Abstracts, No. 134:56548, XP-002190976 (Zhongguo Yaoke Daxue Xuebao, 34(4) (2000), pp. 246-250).
Stadlbauer, W., Synthesis of 4-azido-2(1H)-quinolones, Chemical Abstracts, No. 107:134174, XP-002190977 (Monatsh. Chem., 117(11) (1986), pp. 1305-1323).
Earl, R. et al, “The preparation of 2(1H)-pyridinones and 2,3,-dihydro-5(1H)-indolizinones via transition metal mediated cocyclization of alkynes and isocyanates. A novel construction of the antitumor agent camptothecin”, Chemical Abstracts, No. 102:6913, XP-002190978 (J. Org. Chem. 49(25) (1984), pp. 4786-4800).
Earl, R. et al, “Cobalt-catalyzed cocyclizations of isocyanato alkynes: a regiocontrolled entry into 5-indolizinones. Application to the total synthesis of camptothecin”, Chemical Abstracts, No. 100:85968, XP-002190979 (J. Am. Chem. Soc. 105(23) (1983), pp. 6991-6993).
Fitton, A. et al, “Reactions of formylchromone derivatives. Part 1. Cycloadditions to 2- and 3-(aryliminomethyl)chromones”, Chemical Abstracts, No. 88:22533, XP-002190980 (J. Chem. Soc., Perkin Trans. 1 (12) (1977), pp. 1450-1452).
Moshchitskii, S. et al, “Reactions of diethyl 2,3,5,6-tetrachloro-4-pyridylmalonate”, Chemical Abstracts, No. 73:120466, XP-002190981 (Khim. Geterotsikl. Soedin. (6) (1970), pp. 791-793).
Mao, C. et al, “Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopridyl)]-thiourea (H1-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus”, Bioorganic & Medicinal Chemistry Letters, vol. 9, No. 11, Jun. 7, 1999, pp. 1593-1598.

Affiliated with

Also associated with

Rating

Pyridinone and pyridinethione derivatives having HIV... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridinone and pyridinethione derivatives having HIV..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinone and pyridinethione derivatives having HIV... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3671060